ORBIS INVESTMENT MANAGEMENT LTD 13D and 13G filings for CRISPR Therapeutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 12:26 pm Purchase | 2025-09-30 | 13G | CRISPR Therapeutics AG CRSP | ORBIS INVESTMENT MANAGEMENT LTD | 4,974,125 5.500% | 4,974,125 (New Position) | Filing |